Samsung Display Completes Acquisition of eMagin

Stock Information for Adaptimmune Therapeutics plc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Adaptimmune Therapeutics plc

eMagin Stockholders Approve Acquisition by Samsung Display
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CEQP, BG, AAIC, EMAN
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - TALS, QUOT, NEWR, EMAN
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend eMagin Shareholders Vote "For" Proposed Transaction with Samsung Display
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CIR, BG, AAIC, EMAN
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - EMAN, QUOT, TALS, NEWR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQRX, WMC, EMAN
eMagin Corporation Reports Second Quarter 2023 Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.